CTCF and myelodysplastic syndrome: In spite of apparently discrepant results where BRD9 loss induced MDS and inhibited AML, we observed shared effects of Brd9 KO on chromatin in normal and malignant hematopoietic cells, including enhancing chromatin accessibility at ncBAF/BRD9 and CTCF loci.